Hunter Curry, PharmD retweeted
Friends attending @IDWeekmtg, reminder to join us Friday evening at Calico for a pharmacist & friends gathering! 🥳🤓
For those attending @IDWeekmtg, reminder to please join us Friday, October 23rd, for a pharmacists and friends meet up! See flyer for details.
#IDXPosts #IDWeek2026
Hunter Curry, PharmD retweeted
Reminder: Join your colleagues for a discussion on S. aureus 🦠 bacteremia! 🩸 Topics to be discussed 🗯️: combination therapy 💊 , oral agents 👄 , & role of dalbavancin
The NEW "How We Treat"🩺 series focuses on peer learning, exchange ideas 💡 & collaborations 🧑🤝🧑.
Hunter Curry, PharmD retweeted
Join your colleagues for an informal discussion on S. aureus 🦠 bacteremia 🩸.
The NEW "How We Treat"🩺 series acts like a live ID PRN listserv 💬 , focused on peer learning, exchange ideas 💡 & collaborations 🧑🤝🧑.
Register & let us know what you want to discuss! 🗯️
Hunter Curry, PharmD retweeted
ID PRN members ‼️
Join us June 26 12-1pm CT for
“Beyond the P-Value: Level Up Your Statistical Analyses”
featuring an overview of common statistical analyses followed by expert-led breakout session for demonstration, Q&A & networking. See listserv for registration & Zoom link
Hunter Curry, PharmD retweeted
Check out this retrospective cohort comparing clinical outcomes by cefazolin MIC 🧫 in patients who received oral cephalosporins💊 for Enterobacterales 🦠bacteremias from urinary source
Comparison: cefazolin MIC </= 2 mcg/mL 🆚 4-16 mcg/mL
journals.asm.org/doi/full/10…
Hunter Curry, PharmD retweeted
Good morning world
Let's stop some vancos
De-escalate some meros
Switch some IVs to POs
Optimize antibiotics doses
Escalate some CROS/FEPs
Pre-round targets #IDXposts
Hunter Curry, PharmD retweeted
🚨Attending the ASHP Midyear Meeting this weekend? Meet up with other ID pharmacists at the SIDP & ACCP ID PRN social event on Sunday evening! Food and drink will be available for purchase. RSVP is encouraged (forms.gle/keXndVXrTEyD8hts8). See you there! #IDX
Hunter Curry, PharmD retweeted
🦠 Stenotrophomonas maltophilia infection: monotherapy or dual therapy?
- Crude data: failure 30% vs 34%
Buuut… 😅
- Adjusted analysis: combinations with LEVOFLOXACIN (+minocycline or +cotrimoxazole) ↓ clinical failure risk.
👉academic.oup.com/jacamr/arti…
Happy to see my residency research project finally published!
🆕🔥🦠 Mono vs Combo — S. maltophilia deep-seated infections | JAC AMR 2025 | 190 pts, monomicrobial
🚀 What they did
Focus on levofloxacin-based combos
Propensity-weighted analysis
🔥 Key findings
💊 Levo + minocycline: ~12% clinical failure (vs 30% monotherapy)
💊 Levo + TMP/SMX: ~8% clinical failure (vs 30% monotherapy)
⚠️ Higher risk of Rx failure: high SOFA, prior carbapenems, empyema
💡⚡ Takeaway
Levo combos may reduce clinical failure in deep-seated S. maltophilia infections. Prospective trials are warranted #IDXposts
academic.oup.com/jacamr/arti…
Hunter Curry, PharmD retweeted
I'm thrilled to share our lab's new manuscript on molecular and pharmacodynamic insights into beta-lactam therapy for Enterobacter cloacae high inoculum infections in AAC!
journals.asm.org/doi/10.1128…
Special thanks to the team for their hard work in making this possible, and to @SIDPharm for their generous funding support! @ASMicrobiology
Hunter Curry, PharmD retweeted
🆕💫Insights into β-lactam Rx for high-inoculum(HI)Enterobacter cloacae infections using a 96h SEV model w humanized exposure
Cefepime failed to sustain bactericidal activity across all isolates,consistent w its known vulnerability to AmpC hydrolysis in HI
journals.asm.org/doi/10.1128…
Hunter Curry, PharmD retweeted
🆕💫Antibiotic treatment duration for isolated MSSA native tricuspid valve endocarditis: a standardized multidisciplinary approach( including a CVS ID consult service and multidisciplinary team) #IDXposts #IEWiki @BradSpellberg @DrToddLee @DrEmilyMcD academic.oup.com/jacamr/arti…
Hunter Curry, PharmD retweeted
Join the ACCP ID PRN for Acing That Interview – tips for navigating residency, fellowship, or job interviews.🤝
Date: 9/4 | Time: 4–5 PM EST | Virtual 💻
Refer to ID PRN listserv email 📩to register and Zoom link.
Hunter Curry, PharmD retweeted
Mark your calendars! 🗓️
Join the ACCP ID PRN for Acing That Interview – tips for navigating residency, fellowship, or job interviews.🤝
Date: 9/4 | Time: 4–5 PM EST | Virtual 💻
Open to ACCP ID PRN members (students join free)! Refer to ID PRN listserv email 📩to register!
Hunter Curry, PharmD retweeted
🆕💫Propensity-Matched Comparison of Timely vs. Delayed Antibiotic Therapy in Stenotrophomonas maltophilia Pneumonia #IDXposts
academic.oup.com/ofid/advanc…
Hunter Curry, PharmD retweeted
Families in Eastern Kentucky now have greater access to pediatric expertise thanks to a new collaboration between AdventHealth Manchester and Kentucky Children’s Hospital.
uknow.uky.edu/uk-healthcare/…
Hunter Curry, PharmD retweeted
What’s the optimal cefazolin dose for MSSA CNS infections?
New PK/PD data says: it’s not just about higher doses—MIC matters.
2g q6h works only if MIC <=0.5 mg/L
For MIC:1-2 mg/L, continuous infusion (10–12g/day) may be needed to hit PD targets. #idxposts
journals.asm.org/doi/10.1128…
Hunter Curry, PharmD retweeted
Heading to the @MAD_ID_ASP meeting this week? Don't miss a chance to connect with our own @Ashlan_Kunz, who will deliver two plenary presentations. 🔬
Kunz Coyne will co-present with Romney Humphries on optimizing the use of rapid diagnostic tests, and with Pranita Tamma on emerging and pipeline antimicrobial agents.
#MADID2025 #TwitteRx
Hunter Curry, PharmD retweeted
A positive urinalysis is not a UTI. Please for the good of society can this be properly taught in all medical training programs?
Hunter Curry, PharmD retweeted
Today we are highlighting and congratulating Alex Kim, PharmD and their team for winning “Top Resident/Fellow Research in Progress Poster”. Swipe left to see their poster! This is awarded through ACCP Adult Medicine PRN Walk Rounds Committee at each ACCP Annual Meeting.























